Exploring The Challenges and Insights in Long COVID Treatment and Management

In this epsiode of our Long COVID roundtable with NeurologyLive, clinicians discussed strategies for treating Long COVID, often drawing from approaches used for other chronic illnesses. The panel included:
Ravindra Ganesh, MD (Mayo Clinic)
Svetlana Blitshteyn, MD (University at Buffalo)
Monica Verduzco-Gutierrez, MD (UT Health)
They emphasized the condition's complexity, the lack of FDA-approved therapies, and the importance of individualized care tailored to patient phenotypes, which can vary widely in symptoms and underlying issues. The panel called for more research, improved education for healthcare providers, and increased therapeutic options to better support Long COVID patients.